What is behind Colgate-Palmolive stock's recent gain in value today

Traders Union
All News
Financial News
Colgate-Palmolive rises 2.19% today

Highlights

Colgate-Palmolive reported first quarter 2026 net sales of $5.324 billion, up 8.4% year-over-year with 2.9% organic growth.
Operating cash flow climbed 25% to $747 million, bolstered by improved working capital and stronger net income excluding non-cash items.
Shares are showing sustained bullish momentum above key technical supports, with a projected trading range of $89.42–$95.42 and a 75% probability of further upside.

Sales growth and cash flow boost sentiment despite regional mixed results

Colgate-Palmolive posted first quarter 2026 net sales of $5.324 billion, marking an 8.4% year-over-year increase with 2.9% growth in organic sales. Net cash provided by operations rose 25% to $747 million, supported by changes in working capital and higher net income excluding non-cash items. Growth was recorded across Latin America, Europe, the Middle East & Africa, and Asia Pacific, while North America saw a decline. The company remains focused on its long-term shareholder returns and continued execution of its strategic growth and margin plan.

Anton Kharitonov, expert at Traders Union, views Colgate-Palmolive’s price action as technically extended with short-term risks. He notes the upbeat headline numbers are offset by North America’s sales decline and an intraday gap higher could invite selling pressure. Multiple indicators show buyers remain in control, but neutral ADX and Stochastic RSI warn of fading momentum. Kharitonov questions the sustainability of recent gains without broad-based regional strength. He concludes, "Traders should be wary of chasing upside — a pullback below $89.42 could swiftly erode confidence."

Viktoras Karapetjanc, expert at Traders Union, emphasizes Colgate-Palmolive’s solid Q1 revenue growth and robust operational cash flows. He highlights broad geographical expansion and the company’s focus on strategic margin improvements, which reinforce favorable long-term prospects. Karapetjanc sees the proven uptrend and consistent buyer interest as evidence the bullish structure remains intact. He adds, "With organic growth and strong execution, I expect further upside as the market offers multiple bullish setups in CL."

Jainam Mehta, market strategist, observes that Colgate-Palmolive’s price has broken above all key moving averages, signaling persistent bullish momentum. He notes that short-term volatility and mixed signals from oscillators suggest the possibility of a rangebound phase before the next move. Mehta warns of potential profit-taking if the price fails to clear resistance near $95.42. He concludes, "Opportunistic traders may look for tactical entries on any retracement, given the volatility band and swing potential."

Momentum turns positive as buyers dominate amid mixed indicator signals

Momentum indicators show a bullish tilt: the MACD remains in buy territory while the ADX signals a neutral trend, indicating moderate trend strength without a dominant force. The RSI is at 59.54, still supporting bullish momentum without overbought conditions, and the CCI further supports the uptrend, though the Stochastic RSI points to a strong sell with early signs of moderation. The nearest dynamic support is the Ichimoku Kijun level at $86.65, and the next technical resistance is around the MA-50. Bull/Bear Power (BBP) is strongly positive at 1.94, confirming buyers are in control intraday, as the stock is trading near session highs following a gap higher and 2.67% intraday volatility.

Earlier, analysts noted that Colgate-Palmolive was demonstrating sustained bullish momentum supported by ongoing dividend growth and institutional investment. The latest earnings-driven rally further strengthens this positive narrative, with traders now watching for a potential breakout above $95.42 as the next catalyst for continued upside.

Source of Data: CL Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.